T2 Hyperintensity in the Pons: Evaluation and Management
A T2 hyperintense pontine lesion requires immediate MRI with gadolinium contrast to differentiate between demyelinating disease (particularly multiple sclerosis), vascular malformations, and ischemic changes, with the imaging characteristics and enhancement pattern determining the next steps.
Initial Imaging Protocol
The first step is obtaining a complete brain MRI with specific sequences 1:
- T2-weighted FLAIR sequences (preferably 3D) for lesion identification
- Gadolinium-based contrast (macrocyclic agents preferred) with minimum 5-minute delay before T1-weighted imaging
- Susceptibility-sensitive sequences (gradient-echo) at maximum 1.0 mm isotropic resolution
- T1-weighted post-contrast sequences to detect enhancement patterns
The imaging should use 1.5T or 3T systems with in-plane resolution of maximum 1 × 1 mm and slice thickness ≤3 mm 1.
Differential Diagnosis Based on Imaging Characteristics
If Enhancement Present with Minimal T2 Signal Change
Suspect vascular malformation (capillary telangiectasia) if you see 2:
- Discrete enhancement with irregular or "brushlike" borders
- Minimal or no T2 prolongation despite enhancement
- Anomalous draining vessel from lesion to pons surface (present in 67% of cases)
- Marked T2 shortening on gradient-echo sequences
- No mass effect or hemorrhage
These lesions are benign and require only imaging follow-up, not biopsy. The gradient-echo hypointensity represents elevated intravascular deoxyhemoglobin from stagnant flow 2.
If T2 Hyperintense Without Enhancement
Evaluate for three main possibilities:
1. Demyelinating Disease (Multiple Sclerosis)
- Look for dissemination in time and space
- Check for central vein sign on susceptibility-weighted imaging 1
- Obtain spinal cord imaging to demonstrate additional lesions
- New lesions on follow-up MRI (can be done without contrast) establish dissemination in time 1
2. Ischemic Rarefaction/Small Vessel Disease
- Associated with periventricular leukoaraiosis and lacunar infarcts 3
- More common in patients with atherosclerotic risk factors
- 23% prevalence in patients with symptomatic atherosclerosis 3
3. Metabolic Pontine Lesions
- Large "peach-like" configurations strongly associated with diabetes mellitus (54% vs 15%) and chronic kidney disease (57% vs 29%) 4
- These lesions can expand, shrink, or fluctuate over time
- Do not necessarily correlate with supratentorial white matter disease 4
- When present without supratentorial changes: 85% have diabetes, 85% have CKD 4
Critical Pitfalls to Avoid
Artifact Recognition: A 2-3 mm central pontine hyperintensity can be a volume-averaging artifact from the interpeduncular cistern, not pathology 5. This is exactly midline and has no clinical correlation.
Not Central Pontine Myelinolysis: Isolated pontine T2 hyperintensities found incidentally are heterogeneous and often represent ischemic rarefaction rather than CPM 6. True CPM requires clinical correlation with electrolyte disturbances, alcoholism, or liver disease.
Management Algorithm
Step 1: Obtain complete MRI with gadolinium as outlined above
Step 2: If enhancing with minimal T2 change → Likely vascular malformation
- Follow-up MRI at 3-6 months to confirm stability
- No biopsy needed 2
Step 3: If T2 hyperintense without enhancement → Check for:
- Other CNS lesions (brain and spine) → Consider MS workup 1
- Periventricular leukoaraiosis + lacunar infarcts → Vascular etiology 3
- Diabetes + CKD with large "peach-like" lesion → Metabolic pontine lesion 4
Step 4: If isolated and asymptomatic with no clear etiology:
- Repeat MRI in 3-6 months without contrast (new T2 lesions sufficient for MS diagnosis) 1
- Screen for diabetes and renal function 4
- Assess cardiovascular risk factors 3
The key is that gadolinium administration at initial presentation is essential 1 because the enhancement pattern immediately narrows your differential and prevents unnecessary workup or biopsy for benign vascular lesions that would otherwise appear concerning.